IBMS/ECTS 2001 - PROGRAM and ABSTRACTS
SPONSORING ORGANISATIONS
IBMS - International Bone and Mineral Society
The International Bone and Mineral Society (IBMS) is a major international Society for promoting the generation and dissemination of knowledge in the basic biology and clinical science of the skeleton and mineral metabolism. IBMS comprises approximately 1,500 researchers and clinicians from over 55 countries active in the fields of cell and molecular biology, orthopedics, osteoporosis, and rheumatology. Main benefits of membership include hardcopy and full-text online subscription to the renowned journal BONE, a members-only section at the IBMS web site, reduced registration fees at IBMS and IBMS-supported meetings, and other privileges.
Early in 2001 IBMS launched the new Knowledge Environment - BoneKEy-Osteovision.
IBMS also collaborates closely with many national and regional bone and mineral societies all over the world. For more information about the IBMS please contact: International Bone and Mineral Society 2025 M Street NW, Suite 800 Washington, DC 20036, USA Phone: +1 202 367 1121 Fax: +1 202 367 2121 Email: IBMS@dc.sba.com URL: http://www.IBMSonline.org BoneKEy-Osteovision: http://www.bonekey-ibms.org
IBMS EXECUTIVE COMMITTEE
- President: R. Graham Russell (Oxford/UK)
- Vice-President: Gideon A. Rodan (West Point, PA/USA)
- Secretary/Treasurer: Ian R. Reid (Auckland/New Zealand)
- Immediate Past President: Francis H. Glorieux (Montréal, Quebec/Canada)
- 2001 Meeting Chair: Aurelio Rapado (Madrid/Spain)
- 1998 Meeting Chair: Gordon J. Strewler (Boston, MA/USA)
IBMS BOARD OF DIRECTORS
- Roland Baron (New Haven, CT/USA) * - Editor in Chief
- Jean Philippe Bonjour (Geneva/Switzerland)
- Elisabeth H. Burger (Amsterdam/The Netherlands)
- Bess Dawson-Hughes (Boston, MA/USA)
- John Eisman (Sydney, NSW/Australia)
- Francis H. Glorieux (Montréal, Quebec/Canada) *
- David Goltzman (Montréal, Quebec/Canada)
- John Kanis (Sheffield/UK)
- Toshio Matsumoto (Tokushima/Japan)
- Gegory R. Mundy (San Antonio, TX/USA)
- Socrates Papapoulos (Leiden/The Netherlands)
- Aurelio Rapado (Madrid/Spain) *
- Ian R. Reid (Auckland/New Zealand)
- René Rizzoli (Geneva/Switzerland)
- Gideon A. Rodan (West Point, PA/USA)
- R. Graham Russell (Oxford/UK) *
- Gordon J. Strewler (Boston, MA/USA)
- Steven L. Teitelbaum (St. Louis, MO/USA)
- Alberta Zallone (Bari/Italy)
- Reinhard Ziegler (Heidelberg/Germany)
- * ex-officio
ECTS - European Calcified Tissue Society
The European Calcified Tissue Society is the major organisation in Europe for researchers and clinicians working in the field of calcified tissues and related fields. The Society acts as a forum for the dissemination of high quality research through its annual meeting and workshops. Benefits of membership include free or reduced subscription to the journals Calcified Tissue International and Osteoporosis International. Membership is open to anyone working in the field at whatever stage in their career and from anywhere in the world.
- For more information about the ECTS please contact:
- European Calcified Tissue Society (ECTS)
- PO Box 4
- Dursley GL11 6YL, UK
- Tel: + 44 (0)1453 549929
- Fax: + 44 (0)1453 548919
- Email: admin@ectsoc.org
- URL: http://www.ectsoc.org
ECTS OFFICERS
- President: Professor Stuart Ralson (Aberdeen/UK)
- Secretary: Dr Hans van Leeuwen (Rotterdam/The Netherlands)
- Treasurer: Professor Anna Teti (Rome/Italy)
ECTS COUNCIL
- Paolo Bianco (Rome/Italy)
- Bente Langdahl (Aarhus/Denmark)
- Jean-Jacques Body (Brussels/Belgium)
- Juliet Compston (Cambridge/UK)
- Adolfo Díez-Pérez (Barcelona/Spain)
- Schmuel Hurwitz (Bet Dagan/Israel)
- Klaus Klaushofer (Vienna/Austria)
- Peter Lakatos (Budapest/Hungary)
- Ulf Lerner (Umea/Sweden)
- Clemens Löwik (Leiden/The Netherlands)
- Pierre Marie (Paris/France)
- Johannes Pfeilschifter (Heidelberg/Germany)
- Jan Stepan (Prague/Czech Republic)
- Ulrich Trechsel (Basle/Switzerland)
- Kalervo Väänänen (Oulu/Finland)
- Slobodan Vukicevic (Zagreb/Croatia)
European Calcified Tissue Society Corporate Members
- Eli Lilly and Company
- Merck Sharp and Dohme
- Procter & Gamble Pharmaceuticals and Aventis Alliance
- Roche